Contact Lanner


Complete the form below for a quick response from a Lanner representative or call us on +44 (0)121 709 6520 or +1 713 532 8008. If you require support, please visit

Remplissez le formulaire ci-dessous pour obtenir une réponse rapide d'un représentant Lanner ou appelez-nous au +33 1 87 16 90 15. Si vous avez besoin d'assistance, merci de vous connecter sur

By submitting your personal details you are confirming agreement with our website terms of use, privacy policy and consent to cookies being stored on your device. En nous transmettant vos données personnelles, vous confirmez votre accord avec les termes d’utilisation de notre site internet et notre politique de confidentialité, et vous acceptez que des cookies soient stockés sur votre appareil.

Thank you for your enquiry.
A member of our team will be in touch as soon as possible.

  • By Lanner
  • In News
  • Posted 04/07/2013

Human Genome Company Selects WITNESS Predictive Simulation Technology

Lanner is delighted to announce that Complete Genomics, developers of a proprietary whole human genome sequencing technology, has invested in its WITNESS predictive simulation platform at Complete Genomics’ Mountain View headquarters, California.

The agreement means WITNESS will become instrumental in simulating and optimizing business processes at Complete Genomics as the company focuses on providing biological researchers with highly accurate, interpretable human genome data ready for interpretation.

Having selected WITNESS based on its ability to rapidly model the complex, interconnected processes used to deliver accurate DNA sequencing, Matt Morenzoni, Biomolecular Systems Scientist, Complete Genomics comments, 

“In an industry driven by innovation, precision and speed it is imperative that the best business outcomes are found most effectively.” 

Mandy Tague, Lanner Director of Business Development, says:

“By choosing predictive simulation to gain insight into the operations of their business, Complete Genomics will be able to make confident decisions that will allow them to meet the increasing demand for their services.”
She continues, “Experimenting with the firm's end-to-end service methods that include process automation, sample preparation, computing infrastructure, and service delivery technology allows Complete Genomics to maximize throughput. This provides the firm's research clients with highly accurate genomic data, assembled and annotated, ready for biological interpretation with optimum efficiency.” 

Loading blog comments..

Post a Comment

Thank you, your comment is awating approval